Vip 6 mg
Main Image

Vip 6 mg

Steroids Dragon Pharma Peptide

$26.40

VIP 6 mg – Vasoactive Intestinal Peptide for Inflammation & Neuroimmune Research

VIP (Vasoactive Intestinal Peptide) is a 28-amino acid neuropeptide naturally produced in the gut, brain, and immune tissues. It is involved in a wide range of physiological processes, including smooth muscle relaxation, immune modulation, gastrointestinal function, and circadian rhythm regulation. This 6 mg (2 mL) vial by Peptide Hubs is a high-purity peptide formulation intended for research use only.

What Is Vasoactive Intestinal Peptide (VIP)?

VIP is a pleiotropic signaling molecule with potent anti-inflammatory and immunomodulatory properties. It plays a critical role in regulating the enteric nervous system, pulmonary function, cardiovascular tone, and neuroprotection. According to published data on PubMed, VIP has been shown to suppress pro-inflammatory cytokines while enhancing regulatory T-cell activity, making it an attractive compound for inflammatory and autoimmune research.

Key Research Applications

  • Gut-brain axis signaling and motility regulation
  • Anti-inflammatory and immunomodulatory models
  • Research into pulmonary hypertension and asthma
  • Neuroprotective peptide in CNS and neurodegenerative models
  • Autoimmune disease and systemic inflammation studies
Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:
Brand: Dragon Pharma
Manufacturer: Dragon Pharma
Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage &amp; Usage Guidelines</h2> <p>Typical preclinical studies use VIP at <strong>2–6 mg per week</strong>, divided into subcutaneous or intravenous injections. Due to its short half-life in vivo, some research protocols utilize stabilized formulations or frequent dosing. VIP is not bioavailable orally and should be handled with sterile technique under lab-controlled conditions.</p> <h3>Synergistic Peptides for Research Stacking</h3> <p>Researchers commonly combine VIP with other anti-inflammatory or neuroactive peptides for synergistic benefit:</p> <ul> <li>BPC-157 – for GI tract healing and gut-brain axis studies</li> <li>Selank – supports neuroimmune balance and stress regulation</li> <li>GHK-Cu – for regenerative and anti-inflammatory synergy</li> <li>SS-31 – mitochondrial protection and oxidative stress modulation</li> <li>Thymalin – systemic immune normalization in aging and chronic disease models</li> </ul> <h3>Safety Profile</h3> <p>VIP has demonstrated a favorable safety profile in early human trials and preclinical models. It does not affect sex hormones or metabolic functions and shows no evidence of toxicity to liver, kidney, or cardiovascular systems. Because of its short half-life, dosing protocols may require precision timing or peptide stabilization methods.</p> <h3>USA Domestic Shipping &amp; Quality Control</h3> <p>Peptide Hubs provides <strong>fast and discreet USA domestic shipping</strong> for VIP 6 mg and all peptide research products. Every vial is manufactured in GMP-compliant labs and batch-tested for purity and sterility. VIP is a high-value research tool for gastrointestinal, neurological, and immune applications.</p> </section> </div>
Reviews:
(0 customer reviews)

Technical Details

Peptide Type
Endogenous Neuropeptide
Peptide Sequence
HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH₂
Peptide Length
28 Amino-Acid Residues
Terminal Form
C-Terminal Amide (-NH₂)
Molecular Formula
C₁₄₇H₂₃₇N₄₃O₄₃S
Molecular Weight
3325.8 g/mol
CAS Number
40077-57-4
PubChem CID
16132369
Primary Receptors
VPAC1 + VPAC2
Receptor Activity
VPAC1 / VPAC2 Agonist
Peptide Family
Secretin / Glucagon Peptide Family

Chat on WhatsApp